These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38470700)

  • 21. Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies.
    Jazbec K; Jež M; Žiberna K; Mali P; Ramšak Ž; Potokar UR; Kvrzić Z; Černilec M; Gracar M; Šprohar M; Jovanovič P; Vuletić S; Rožman P
    Virol J; 2023 Mar; 20(1):53. PubMed ID: 36973781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
    Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.
    Annen K; Morrison TE; DomBourian MG; McCarthy MK; Huey L; Merkel PA; Andersen G; Schwartz E; Knight V
    Transfusion; 2021 Apr; 61(4):1148-1159. PubMed ID: 33452828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors.
    Drews SJ; Devine DV; McManus J; Mendoza E; Manguiat K; Wood H; Girardin R; Dupuis A; McDonough K; Drebot M
    Transfusion; 2021 May; 61(5):1440-1446. PubMed ID: 33734448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.
    Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T
    BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors.
    Holloway K; Campbell C; Ali R; Huyer LD; Hart D; Haw J; Brennenstuhl S; Grundy Q
    Transfus Med; 2022 Oct; 32(5):351-365. PubMed ID: 35578828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the Whole Blood Donor Population in South-West Germany: 2010 versus 2016.
    Müller-Steinhardt M; Weidmann C; Klüter H
    Transfus Med Hemother; 2017 Aug; 44(4):217-223. PubMed ID: 28924426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors.
    Grujić J; Bujandrić N; Budakov-Obradović Z; Dolinaj V; Bogdan D; Savić N; Cabezas-Cruz A; Mijatović D; Simin V; Anđelić N; Banović P
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictors of high titer of
    Wardhani SO; Fajar JK; Nurarifah N; Hermanto DH; Fatonah S; Djajalaksana S; Fatoni AZ; Arsana PM; Wulandari L; Soegiarto G; Dhama K; Harapan H
    Clin Epidemiol Glob Health; 2021; 11():100763. PubMed ID: 33997476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors.
    Leon J; Merrill AE; Rogers K; Kurt J; Dempewolf S; Ehlers A; Jackson JB; Knudson CM
    Transfus Apher Sci; 2022 Apr; 61(2):103326. PubMed ID: 34862140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [COVID-19 - BLOOD GROUPS, ANTIBODIES AND CONVALESCENT PLASMA].
    Izak M; Yahalom V; Maor Y; Zimhoni O; Cohen D; Chen J; Shinar E
    Harefuah; 2021 Mar; 160(3):139-143. PubMed ID: 33749174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda.
    Muttamba W; Lusiba J; Namakula LO; Byakika-Kibwika P; Ssali F; Ddungu H; Mugenyi L; Kiwanuka N; Sekibira R; Kityo C; Keyune D; Acana S; Musinguzi A; Masasi A; Byamugisha J; Mpanju D; Musoki WJ; Tukamuhebwa HA; Nakwagala F; Bagaya BS; Kayongo A; Kimuli I; Nantanda R; Katagira W; Buregyeya E; Byanyima R; Byarugaba B; Siddharthan T; Mwebesa H; Charles O; Joloba ML; Bazeyo W; Kirenga B
    PLoS One; 2021; 16(6):e0252306. PubMed ID: 34138909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.
    Martin MC; Jimenez A; Ortega N; Parrado A; Page I; Gonzalez MI; Blanco-Peris L
    PLoS One; 2022; 17(2):e0264124. PubMed ID: 35202394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motivational factors for blood donation in first-time donors and repeat donors: a cross-sectional study in West Pomerania.
    Suemnig A; Konerding U; Hron G; Lubenow N; Alpen U; Hoffmann W; Kohlmann T; Greinacher A
    Transfus Med; 2017 Dec; 27(6):413-420. PubMed ID: 28786224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these.
    Mahapatra S; Pati S
    Transfus Clin Biol; 2021 May; 28(2):175-179. PubMed ID: 33677086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India.
    Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S
    Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multistep screening and selection of COVID-19 convalescent plasma donors at the early stage of the SARS-CoV-2 pandemic: A retrospective analysis.
    Brosig AM; Ossner T; Pamler I; Friedinger S; Bica AF; Mohrez M; Tlili I; Mueller V; Becke C; Haehnel V; Baeuerlein V; Stemmer B; Burkhardt R; Offner R
    Health Sci Rep; 2022 Sep; 5(5):e815. PubMed ID: 36172300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience.
    Reik R; Gammon RR; Carol N; Smith J; Grable M; Forbes S; Wu Y; Reed L; Rogers M; Prichard A; Paul S; Scholl G
    J Clin Apher; 2021 Aug; 36(4):533-546. PubMed ID: 33648025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies.
    De Silvestro G; Gandini G; Fiorin F; Marson P; Barbone E; Frigato A; Gessoni G; Veronesi A; Pacenti M; Castelli M; Rinaldi M; Rizzi M; Stefani F; Roveroni G
    Transfus Apher Sci; 2021 Aug; 60(4):103154. PubMed ID: 33994107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Repeated Convalescent Plasma Collection: Analysis of 149 Donations from 88 French Military Health Workers.
    Conan PL; Ficko C; Chueca M; Rolland C; Javaudin O; Bigaillon C; Durand GA; Leparc-Goffart I; Verret C; Aletti M; Dutasta F; Savini H; Bosson JL; Martinaud C
    Transfus Med Hemother; 2021 Aug; 395(5):1-6. PubMed ID: 34580580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.